Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Adult Stem Cells

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An X-linked long non-coding RNA, PTCHD1-AS, and the core features of autism.

Nature·2026

Same author

Advanced physiological maturation of human iPSC-derived cardiomyocytes using an algorithm-directed optimization of defined media components.

Nature communications·2026

Same author

Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy.

The New England journal of medicine·2026

Same author

Abnormal Lipid Signaling Characterizes Diastolic Dysfunction in Pediatric Cardiomyopathy.

JACC. Basic to translational science·2026

Same author

DNA methylation analysis of NOTCH1 variants reveals the first episignature for non-syndromic congenital heart defects.

Genome medicine·2026

Same author

Mavacamten in symptomatic adolescent patients with obstructive hypertrophic cardiomyopathy: design of the phase 3 SCOUT-HCM trial.

American heart journal·2025

Search research articles

Related Experiment Video

Updated: May 15, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Stem cells in pediatric cardiology.

Pranali Patel¹, Seema Mital

¹Division of Pediatric Cardiology, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

European Journal of Pediatrics

|January 8, 2013

Summary

Human induced pluripotent stem cells (iPSC) offer a powerful tool for disease modeling and drug discovery, especially for pediatric cardiac genetic disorders. Further research is needed to optimize their use in personalized medicine and therapies.

Area of Science:

Stem Cell Biology
Regenerative Medicine
Genetics

Background:

Human induced pluripotent stem cells (iPSC) represent a significant advancement, enabling cells to revert to an embryonic-like state.
Patient-derived iPSCs facilitate disease modeling in a controlled genetic and environmental context.
iPSCs have shown success in modeling various cardiovascular conditions, including cardiomyopathies and rhythm disorders.

Purpose of the Study:

To review the application of iPSCs in drug discovery and repurposing for genetic cardiovascular disorders, with a focus on pediatric applications.
To highlight the challenges and future directions in utilizing iPSCs for drug development and personalized medicine.

Main Methods:

Review of existing literature on iPSC applications in disease modeling and drug discovery.

More Related Videos

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells

Published on: June 19, 2018

Related Experiment Videos

Last Updated: May 15, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells

Published on: June 19, 2018

Analysis of iPSC-based studies for efficacy and toxicity testing.

Discussion of challenges in pediatric drug discovery using iPSCs.

Main Results:

Patient-derived iPSCs are effective for modeling genetic heart diseases and enabling drug discovery.
iPSCs offer potential for drug repurposing and personalized medicine approaches.
Significant challenges remain in pediatric drug discovery, including iPSC maturation and scalability.

Conclusions:

iPSCs are a valuable tool for studying genetic cardiovascular diseases and advancing drug discovery.
Future efforts should focus on improving iPSC maturation, high-throughput screening, and clinical translation for personalized therapies.
Addressing challenges in pediatric drug discovery is crucial for realizing the full potential of iPSC technology.